Biovica International Ab Stock Fundamentals
| BIOVIC-B | SEK 2.02 0.15 8.02% |
Biovica International AB fundamentals help investors to digest information that contributes to Biovica International's financial success or failures. It also enables traders to predict the movement of Biovica Stock. The fundamental analysis module provides a way to measure Biovica International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biovica International stock.
Biovica |
Biovica International AB Company Current Valuation Analysis
Biovica International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biovica International Current Valuation | 175.91 M |
Most of Biovica International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biovica International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Biovica International AB has a Current Valuation of 175.91 M. This is 98.78% lower than that of the Healthcare sector and 96.21% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 98.94% higher than that of the company.
Biovica International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biovica International's current stock value. Our valuation model uses many indicators to compare Biovica International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biovica International competition to find correlations between indicators driving Biovica International's intrinsic value. More Info.Biovica International AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biovica International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biovica International's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biovica Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biovica International's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biovica International could also be used in its relative valuation, which is a method of valuing Biovica International by comparing valuation metrics of similar companies.Biovica International is currently under evaluation in current valuation category among its peers.
Biovica Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (14.77) % | |||
| Current Valuation | 175.91 M | |||
| Shares Outstanding | 39.47 M | |||
| Shares Owned By Institutions | 3.73 % | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 48.31 X | |||
| Revenue | 2.04 M | |||
| Gross Profit | 4.73 M | |||
| EBITDA | (75.36 M) | |||
| Net Income | (60 M) | |||
| Cash And Equivalents | 89.79 M | |||
| Cash Per Share | 0.71 X | |||
| Total Debt | 8.78 M | |||
| Current Ratio | 2.56 X | |||
| Book Value Per Share | 2.86 X | |||
| Cash Flow From Operations | (52.13 M) | |||
| Earnings Per Share | (2.11) X | |||
| Target Price | 22.6 | |||
| Number Of Employees | 27 | |||
| Beta | 1.02 | |||
| Market Capitalization | 403.5 M | |||
| Total Asset | 151.63 M | |||
| Z Score | 27.0 | |||
| Net Asset | 151.63 M |
About Biovica International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biovica International AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovica International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovica International AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Biovica International AB , a biotech company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. Biovica International AB was founded in 2009 and is based in Uppsala, Sweden. Biovica International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biovica Stock
Biovica International financial ratios help investors to determine whether Biovica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovica with respect to the benefits of owning Biovica International security.